| Autor: |
Florencia McAllister, Eduardo Vilar, David R. Fogelman, Andrew Futreal, Lei Feng, Matthew H. Katz, Anirban Maitra, Gauri R. Varadhachary, Merve Hasanov, Ester Borras, Maureen E. Mork, Wenli Dong, Jennifer B. Goldstein, Maria F. Montiel, Sarah A. Bannon |
| Rok vydání: |
2023 |
| DOI: |
10.1158/1940-6207.22534385.v1 |
| Popis: |
Supplementary Table 1. Criteria for Referral of PDAC patients Supplementary Table 2. Comparison patients tested and non-tested patients in the HRC. Supplementary Table 3. Mutation nomenclature and classification Supplementary Table 4. NCCN guidelines for pancreatic cancer testing Supplementary Table 5. Analysis of patients who met NCCN guidelines Supplementary Table 6. Patient from General Cohort Supplementary Table 7. Comparison of General Cohort patients according to mutational status Supplementary Table 8. Comparison of HRC tested by Panel or by Single gene testing. Supplementary Fig 1. Figure depicting percent of tested patients by panel vs. targeted testing with positive pathogenic mutations or VUS results in the young onset HRC. ***p value |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
